MITF and neoplasm: Intra-vital imaging of an engineered mouse melanoma cell line, expressing GFP driven by a BRN2 promoter, has demonstrated motile, invasive cells leaving the site of the primary tumor had high expression of BRN2 while lacking pigmentation suggesting loss of MITF expression17.